Adial Pharmaceuticals, Inc. Grants Receivable
Adial Pharmaceuticals, Inc. (ADIL) had Grants Receivable of $1.00 million as of 2018-04-01, per its 10-K filed 2026-03-05.
Financial Statements › Notes
us-gaap:GrantsReceivable · last filed 2026-03-05
- 2018-04-01: Grants Receivable $1.00M.
| Period end | Grants Receivable |
|---|---|
| 2018-04-01 | $1.00M 10-K · filed 2026-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |